TXN and cardiac hypertrophy: These post-translational modifications, leading to the inactivation of Trx1, cause direct activation of its interacting molecules, increasing ROS, and the formation of disulfide bonds between cysteine residues in normal cardiomyocytes, thereby causing myocardial hypertrophy.